Lutetium Lu-177 Vipivotide Tetraxetan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium Lu-177 Vipivotide Tetraxetan, covering 2025-12-02 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC [Phase 1, Phase 2]